CGS 22652
has thromboxane receptor antagonism combined with thromboxane synthase inhibition; structure given in first source
Also Known As:
8-(((4-chlorophenyl)sulfonyl)amino)-4-(3-(3-pyridinyl)propyl)octanoic acid; 8-((4-chlorophenylsulfonyl)amino)-4-(3-(3-pyridinyl)propyl)octanoic acid; 8-CSAPOA; CGS-22652
Networked: 4
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results
Experts
1. | Abran, D:
1 article
(06/2001)
|
2. | Almazan, G:
1 article
(06/2001)
|
3. | Beauchamp, M H:
1 article
(06/2001)
|
4. | Chemtob, S:
1 article
(06/2001)
|
5. | Gobeil, F:
1 article
(06/2001)
|
6. | Hou, X:
1 article
(06/2001)
|
7. | Lachapelle, P:
1 article
(06/2001)
|
8. | Marrache, A M:
1 article
(06/2001)
|
9. | Martinez-Bermudez, A K:
1 article
(06/2001)
|
10. | Quiniou, C:
1 article
(06/2001)
|
Related Diseases
Related Drugs and Biologics
Related Therapies and Procedures